Interleukin-12/23 and Interleukin-23 Inhibitors for the Treatment of Cutaneous Crohn's Disease: A Case Series From a Multi-Institutional Registry JEADV Clinical Practice June 2025;4(2):458-462
Date
06/01/2025
DOI
10.1002/jvc2.615Scopus ID
2-s2.0-85216187071 (requires institutional sign-in at Scopus site)
Author List
McKay GE, Coromilas A, Liu L, Shaw KS, Murphy M, Punyamurthy N, Soltero KMS, Damsky W, Wanat KA, Charrow AP, Rosenbach M, Caplan A, LaSenna CE, Arkin L, Shields BE
Author
Karolyn A. Wanat MD Chair, Professor in the Dermatology department at Medical College of Wisconsin